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Introduction
Perioperative management for cardiac surgery in patients with liver
cirrhosis is often complicated due to various factors associated with
altered liver function, such as bleeding tendency, undernutrition,
susceptibility to infection, and difficulty in controlling body fluid
balance.1,2 The surgical mortality rate in such patient group has been
reported to be 18-80% in class B and 67-100% in class C according
to the Child-Pugh classification.1-5 It is important to investigate the
relationship between the severity of liver disease and surgical out-
comes, and clarify the indication for cardiac surgery. In this study,
we therefore retrospectively evaluated the perioperative factors, post-
operative morbidity and mortality rate in patients with liver cirrhosis
who had undergone cardiac surgery in our institute, and discussed
the therapeutic strategy for perioperative management.
Patients and Methods
Of the 1374 patients who underwent cardiac surgery at Nagasaki
University Hospital between May 1999 and December 2007, 21 pa-
tients with the diagnosis of liver cirrhosis were identified (1.5%).
Table 1 shows the background of the patients. The patients consisted
of 17 males and 4 females with a mean age of 66.0 ± 9.7 years (38-
79 years). Liver cirrhosis was diagnosed in all patients based on
characteristic morphological changes in the liver observed by ab-
dominal ultrasonography, computed tomography, or magnetic reso-
nance imaging.6 Liver cirrhosis-related complications, such as ascites,
gastroesophageal varices, and thrombocytopenia, were also taken into
account. The severity of liver cirrhosis was determined according to
the Child-Pugh classification.7 Preoperative hepatic reserve was moni-
tored using the 15-min indocyanine green retention rate (ICG R-15)
and serum total bilirubin value. Preoperative cardiac function was
evaluated by the New York Heart Association classification of car-
diac performance, cardiac ultrasonography, and cardiac catheterization.
The medical records of these patients were reviewed in detail with
respect to the perioperative course.
The surgical procedures were as follows: Under general anesthesia,
cardiopulmonary bypass (CPB) was initiated between the ascend-
ing aorta and either the right atrium or both cavae through median
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sternotomy. In patients to whom conventional CPB was applied,
roller pumps with a membrane oxygenator and a heparin-coating
circuit were used. Initially, the dose of heparin was 200 units per
body weight, and its administration was controlled to maintain the
activated clotting time (ACT) at more than 400 sec. St. Thomas
second solution (Miotecter®, Mochida Pharmaceutical Co. Ltd.) was
used for myocardial protection. In 1 of the patients who underwent
coronary artery bypass grafting (CABG), a mini-pump system using
percutaneous cardiopulmonary support circuit was applied. According
to a study of Takai et al., the mini-pump system consisted of a cen-
trifugal pump, membrane oxygenator, and heparin-coating circuit
with a soft reservoir.8 The initial dose of heparin in the mini-pump
system was 100 units per body weight and the ACT was targeted to
more than 250 sec. In patients who underwent off-pump coronary ar-
tery bypass (OPCAB), the initial dose of heparin was 100 units per
body weight. Blood transfusion was performed if necessary.
The operation time, CPB time, aortic clamp time, blood loss dur-
ing surgery, chest tube output during the 24 hours after surgery,
blood transfusion during and after surgery, and postoperative compli-
cations were recorded. Postoperative complications were classified
into neurological (cerebral infarction, cerebral hemorrhage, and
encephalopathy), respiratory (pneumonia, conditions requiring more
than 48-hour mechanical ventilation, and those requiring tracheotomy),
infection (deep sternal infection and sepsis), gastrointestinal (gastro-
intestinal hemorrhage and hepatic decompensation), renal (newly re-
quiring hemodialysis), and hemorrhage (requiring reexploration for
bleeding). The operative mortality was defined as death during a
hospitalization or within 30 days after surgery. Metric parameters
were expressed as the mean ± standard deviation or the median and
range. The relationships between the perioperative parameters and
postoperative complications were examined by non-parametric tests
(Mann-Whitney U test and chi-square test). Statistical analysis was
performed using SPSS version 11.0 (SPSS Inc., Chicago, IL, USA),
and a value of p<0.05 was regarded as significant.
Results
As shown in Table 2, the causes of liver cirrhosis were viral hepa-
titis in 14 patients, alcohol in 2, autoimmune hepatitis in 1, conges-
tive liver in 2, and unknown in 2. All patients with liver cirrhosis
caused by viral hepatitis showed hepatitis C virus (HCV) positive.
According to the Child-Pugh classification, 13 patients were in class
A, 7 in class B, and 1 in class C. The preoperative ICG R-15 ranged
from 7.0% to 37.0%, and it was 18.8 ± 10.0% in class A and 22.4
± 9.8% in class B. In the 1 patient of class C, the preoperative ICG
R-15 was not measured, because of emergency operation. The pre-
operative total bilirubin was 0.7 ± 0.4 mg/dL in class A, 1.5 ± 1.2












































































Table 1. Patient Characteristics
AR=aortic regurgitation, AS=aortic stenosis, ASR=aortic stenosis and regurgitation,
CAD=coronary artery disease, COPD=chronic obstructive pulmonary disease, CRI=
chronic renal insufficiency, IE=infective endocarditis, MI=myocardial infarction,
MR=mitral regurgitation, NYHA=New York Heart Association, PS=pulmonary stenosis,



















































Table 2. Preoperative liver profile and laboratory tests
ICG R-15=Indocyanine green retention rate 15 minutes after injection
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varices were detected in 9 patients, of whom 1 patient underwent
balloon occluded retrograde transvenous obliteration before cardiac
surgery.
Table 3 shows the outlines of cardiac surgery. CABG was per-
formed in 7 patients, surgery for valvular disease in 10, simultane-
ous CABG and valvular procedure in 1, surgery for constrictive
pericarditis in 2, and right atrial thrombectomy in 1. Of the patients
who underwent CABG, OPCAB was performed in 3, and surgery
using mini-pump system was performed in 1. Two patients under-
went emergency operation. Reoperation was performed in 5 patients.
The mean duration of operation was 278 ± 83 min, the mean CPB
time 129 ± 53 min, and the mean aortic clamp time 75 ± 33 min.
The mean blood loss within 24 hours after surgery was 751 ± 767 mL
(122-3,227 mL). The blood transfusion during surgery was 5 ± 4
units for packed red blood cells, 5 ± 4 units for fresh frozen plasma,
and 9 ± 9 units for platelets. The median mechanical ventilation time
was 9.0 hours (3.0-82.0 hours). The median duration of intensive
care unit stay and hospital stay after surgery were 3 days (1-23 days)
and 20 days (14-167 days), respectively.
The postoperative complications include newly requiring hemodialysis
in 2 patients, mechanical ventilation more than 48-hour in 2,
mediastinitis in 1, and postoperative hepatic insufficiency in 1. The
incidence of perioperative complications was 8% in class A, 29% in
class B, and 100% in class C. The preoperative hemoglobin level
was significantly lower in the patients with the postoperative compli-
cations (Table 4, p=0.009). There was one case of operative mortal-
ity. This patient, who had undergone mitral valve replacement and
pericardiectomy, was in class B before the reoperation for the
pericardiectomy. In this patient, the preoperative hemoglobin level
was 9.2 g/dL, the operation time was 259 min, the CPB time was
152 min, and the blood loss during surgery was 3,360 mL. The pre-
operative total bilirubin was 4.0 mg/dL, which was highest in all pa-
tients. Postoperatively, the irreversible hepatic insufficiency was ag-
gravated, requiring tracheotomy and continuous hemodiafiltration,
and the patient died from multiple organ failure 23 days after sur-
gery. Excluding this patient, the highest postoperative total bilirubin
was 1.6 ± 0.8 mg/dL in class A, 2.2 ± 0.9 mg/dL in class B, and 2.1
mg/dL in class C. The surgical mortality rate was 0% in class A,
14% in class B, and 0% in class C.
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Table 3. Operative data and clinical outcome
CABG=coronary artery bypass grafting, CPB=cardiopulmonary bypass, ICU=intensive care unit
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Discussion
With the development of surgical techniques, CPB equipment and
perioperative management, less invasive surgical procedure has ad-
vanced in cardiac surgery. Application of surgical treatment has
been spread in patients with severe comorbidities and the operative
outcomes are improving.9 Among patients with various preopera-
tive complications, the morbidity and mortality rate following car-
diac surgery are still high in patients with liver cirrhosis, and there
is no evidence for the selection of patients, indication for surgical
treatment, standard methods for preoperative evaluation of risks, or
guidelines for perioperative management.10 Since the prognosis of
cardiac surgery is poor in patients with severe liver cirrhosis, refer-
ence of such patients to the surgical department may be often hesi-
tated right from the start, resulting in the limited number of patients
with liver cirrhosis who underwent cardiac surgery. Therefore, the
number of studies on cardiac surgery performed in patients with liver
cirrhosis is also limited. To improve the outcomes of surgical treat-
ment for cardiac disease in patients with liver cirrhosis, we consid-
ered it important to accumulate data from a larger number of such
patients and investigate their operative results.
There are various causes of liver cirrhosis, such as hepatitis viruses,
alcohol abuse, autoimmune hepatitis, chronic cholestasis, metabolic
disorders, and cardiogenic congestive liver. Since the hepatitis virus-
infection rate is higher in Asia than in Europe and America,11 the
percentage of patients with liver cirrhosis in those who undergo car-
diac surgery could be relatively high in the former. In our study, the
percentage of liver cirrhosis caused by hepatitis viruses was 66.7%,
and all patients showed HCV positive. Filsoufi et al. reported that
the percentage of patients with liver cirrhosis in those who underwent
cardiac surgery was 0.5%,12 while in our study, it was 3-fold higher
(1.5%).
Table 5 shows the studies on cardiac surgery performed in pa-
tients with liver cirrhosis (more than 10 patients).1-5,12-14 The mortal-
ity rate was 0-10% in class A and 18-80% in class B, according to
the Child-Pugh classification. In these studies, cardiac surgery was
performed in 11 patient of Child-Pugh class C, and there were 7
operative deaths. The morbidity rate was 15-100% in class A, 33-
100% in class B, and 100% in class C. In our study, the mortality
rate was 0% in class A, 14% in class B, and 0% in class C. The
18
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Table 4. Possible predictive factors for postoperative morbidity in patients with cirrhosis undergoing
cardiac surgery
CPB=cardiopulmonary bypass, NYHA=New York Heart Association, ICG R15=Indocyanine green retention rate
15 minutes after injection, S-Cre=serum creatinine
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morbidity rate was 8% in class A, 29% in class B, and 100% in class
C. We encountered 1 patient in class C, who underwent emergency
surgery for critical condition of infective endocarditis of the aortic
and mitral valves after renal transplantation for chronic renal insuf-
ficiency. Although long-term postoperative mechanical ventilation
was required, this patient was discharged after relief without other
complications. Since the surgical mortality rate in class C is very
high, the application of cardiac surgery to patients, except for those
who cannot be treated for critical condition other than surgical treat-
ment, should be evaluated with caution. In the patients shown in
Table 5, OPCAB was performed in 10 patients, including our 3 pa-
tients, no surgical mortality was observed. In our 3 patients, the post-
operative courses were satisfactory, indicating that OPCAB is useful
for the coronary revascularization in patients with liver cirrhosis.15,16
The severity of liver cirrhosis is generally evaluated using the Child-
Pugh classification.7 In this classification, ascites, psychoneurotic
symptoms (hepatic encephalopathy), serum bilirubin, albumin, and
prothrombin time were scored in 1 to 3 points, and total scores of
5-6, 7-9, and more than 10 points are defined as classes A, B, and C,
respectively. This classification method is simple to conduct, and the
correlations between the Child-Pugh class and surgical mortality or
the incidence of complications are considered high.12 In cardiac
surgery, the evaluation of patients with liver cirrhosis is often per-
formed using the Child-Pugh classification.1,3 The model for end-
stage liver diseases (MELD) score is also often used for the post-
operative prediction of transjugular intrahepatic portosystemic shunt
treatment and liver transplantation.17 Suman et al. reported that the
MELD score was useful for the prediction of mortality and hepatic
insufficiency after cardiac surgery in patients with liver cirrhosis.14
On the other hand, Filsoufi et al. reported that the Child-Pugh clas-
sification was more useful for the prediction of hospital mortality
than the MELD score.12 As the prognosis-determining factors for
surgical mortality, the preoperative serum total bilirubin, cholinester-
ase, and CPB time have been reported.5,18 In the present study, only
1 patient died, of whom the preoperative total bilirubin was high-
est. The ICG R-15 is often used for the evaluation of preoperative
hepatic reserve,19 but it was not significantly correlated with postop-
erative complications in our study. It has been reported that
histological findings in liver cirrhosis were sometimes not corre-
lated with the ICG R-15 values in the presence of shunts.20
Therefore, it is necessary to evaluate the relationship between the
ICG R-15 and surgical mortality or the prognosis by accumulating
data from a larger number of patients. Takami et al. has reported
the usefulness of asialoscintigraphy for the evaluation of hepatic
reserve in such patient group undergoing cardiac surgery.21
In patients with liver cirrhosis, postoperative complications are
caused by liver cirrhosis or its related complications. Briefly, the
proliferation of the fibrous partition and connective tissues in the
liver causes changes in hepatic vascular resistance, resulting in
portal hypertension. Portal hypertension causes gastroesophageal
varices, gastrointestinal hemorrhage, fluid retention tendency, such
as pleural effusion and ascites, hepatic encephalopathy induced
by hyperammonemia, and thrombocytopenia by hypersplenism.10
Decreases in hepatic cells cause the reduction of protein-
synthesizing ability and abnormalities in the bilirubin metabolism,
resulting in hypoalbuminemia, coagulopathy, and hyperbilirubinemia.
In very advanced hepatic dysfunction, fibrinolytic capacity is en-
hanced, and severe hemorrhage is often induced synergetically by
thrombocytopenia and coagulopathy.22 In our patients with postop-
erative complications, the preoperative hemoglobin level was sig-
nificantly low. It has been reported that a higher hematocrit value
is advantageous for hepatic blood flow during extracorporeal circu-
lation, and the correction of the hemoglobin level is important.23
Klemperer et al. has reported that blood transfusion was required
19
Author Year CPB use n Number of patients Mortality (%) Morbidity (%)
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Table 5. Clinical Studies in patients with cirrhosis undergoing cardiac surgery
CPB=cardiopulmonary bypass
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for cardiac surgery in patients with liver cirrhosis at 3-fold higher
rate than for patients without cirrhosis.3 Therefore, it is important
to prepare a sufficient amount of blood for transfusion, but exces-
sive blood transfusion could further aggravate the hepatic function.
OPCAB tends to require a smaller amount of blood for transfusion
than surgery under conventional CPB, indicating that this method
is advantageous for the myocardial revascularization in patients with
liver cirrhosis.24 No postoperative complications were observed in
patients who had undergone CABG using off-pump or mini-pump
procedure in our study. Even though there still remains the possi-
bility that well preserved preoperative hemoglobin level might ex-
plain satisfactory postoperative course, because of a smaller dose
of heparin than that for conventional CBP and smaller effect on the
coagulation and fibrinolytic systems,8 we thought these methods
are very useful in such patient group. The mini-pump system can be
applied to surgical treatment for valvular diseases, and the release of
inflammatory cytokines or vascular reactants is lower in this system
than in conventional CPB, indicating that this system could improve
operative results in patients with liver cirrhosis.25
Postoperaive infection and fluid-retention tendency are also major
concern in this patient group.13 In our study, we encountered 1 patient
with postoperative mediastinitis in class B. This patient had been ad-
ministered steroids for the treatment of autoimmune hepatitis and sys-
temic lupus erythematosus. In patients with liver cirrhosis, it is neces-
sary to improve nutritional conditions before surgery, reduce the CPB
time, and carefully perform hemostasis to avoid reexploration. There
are perioperative risks, such as hypoalbuminemia, ascites caused by
portal hypertension, pleural effusion or pericardial fluid, and fluid re-
tention in a third space.26 These symptoms cause difficulties in fluid
control and respiratory management. The advancement of hepatic
dysfunction causes hepatorenal syndrome, and further fluid reten-
tion, sodium retention, and renal dysfunction could be induced.14
Atrial natriuretic peptides are reported to be useful for perioperative
fluid balance control in patients with liver cirrhosis.27 Among prob-
lematic postoperative complications in patients with liver cirrhosis,
factors induced by altered liver function, such as bleeding tendency,
susceptibility to infection and hepatorenal syndrome is more respon-
sible for poor operative results than postoperative cardiac dysfunc-
tion.12 To improve the operative outcome of these patients, over-
coming these complications is mandatory.
There are several limitations in this study. Since this study was
retrospectively performed, the characteristics of such a method must
be taken into account and any conclusions should be limited in their
implication. Since patients with liver cirrhosis, in whom risks for
surgical treatment are judged unacceptably high by physicians, are
not referred for cardiac surgery to the surgical department, such pa-
tients may not be included. Although the number of patients in our
study was relatively large compared to past studies, it was still in-
sufficient for analyzing the relationship between preoperative fac-
tors and complications or surgical mortality.
In conclusion, our findings indicate acceptable mortality rate in each
severity of liver cirrhosis compared to previous reports. However,
the incidence of severe complications, such as prolonged ventilation,
mediastinitis and irreversible hepatic insufficiency was still high and
problematic in class B and class C patients. In patients with severe
liver cirrhosis, the preoperative hemoglobin level and total bilirubin
value should be controlled meticulously to improve surgical out-
come. With the increase in the application of less invasive cardiac
surgery, such as the use of mini-pump system or off-pump proce-
dure, surgical outcomes will be improved in patients with severe
liver disease.
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